Supply Of 1) TENOFOVIR 300 MG+LAMIVUDINE 300 MG+DOLUTEGRAVIR 50 MG TAB, 2) STAVUDINE 30 MG + LAMIVUDINE 150 MG TAB, 3) ATAZANAVIR 300 MG + RITONAVIR 100 MG TAB / CAP, 4) ZIDOVUDINE 300 MG + LAMIVUDINE 150 MG TAB & 5) ZIDOVUDINE 300 MG LAMIVUDINE 150
Tender Overview
Project Description
Supply Of 1) tenofovir 300 mg+lamivudine 300 mg+dolutegravir 50 mg tab, 2) stavudine 30 mg + lamivudine 150 mg tab, 3) atazanavir 300 mg + ritonavir 100 mg tab / cap, 4) zidovudine 300 mg + lamivudine 150 mg tab & 5) zidovudine 300 mg lamivudine 150 mg nevirapine 200 mg oral tablet , srphc82028285-zidovudine 300 mg + lamivudine 150 mg tab [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ] , srphc82028275-stavudine 30 mg + lamivudine 150 mg tab [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ] , srphc82028070-atazanavir 300 mg + ritonavir 100 mg tab / cap [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ] , srphc82028495-zidovudine 300 mg lamivudine 150 mg nevirapine 200 mg oral tablet [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ] , srphc82028120-tenofovir 300 mg+lamivudine 300 mg+dolutegravir 50 mg tab [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]
BOQ
| Sl. No. | Item Description |
|---|---|
| 1 | SRPHC82028285-ZIDOVUDINE 300 MG + LAMIVUDINE 150 MG TAB [Quantity Tolerance (+/-): 5 %age , Item Category : Normal , Total PO value variation Permitted: Max 8 lacs ] ] |
| 2 | SRPHC82028275-STAVUDINE 30 MG + LAMIVUDINE 150 MG TAB [Quantity Tolerance (+/-): 5 %age , Item Category : Normal , Total PO value variation Permitted: Max 8 lacs ] ] |
| 3 | SRPHC82028070-ATAZANAVIR 300 MG + RITONAVIR 100 MG TAB / CAP [Quantity Tolerance (+/-): 5 %age , Item Category : Normal , Total PO value variation Permitted: Max 8 lacs ] ] |
| 4 | SRPHC82028495-ZIDOVUDINE 300 MG LAMIVUDINE 150 MG NEVIRAPINE 200 MG ORAL TABLET [Quantity Tolerance (+/-): 5 %age , Item Category : Normal , Total PO value variation Permitted: Max 8 lacs ] ] |
| 5 | SRPHC82028120-TENOFOVIR 300 MG+LAMIVUDINE 300 MG+DOLUTEGRAVIR 50 MG TAB [Quantity Tolerance (+/-): 5 %age , Item Category : Normal , Total PO value variation Permitted: Max 8 lacs ] ] |
AI Tender Summary
Tender Timeline
Tender Published
Tender notice published.
CompletedBid Submission Deadline
Online submission via eProcurement portal.
Upcoming · 12 daysTender Documents
Download All (ZIP) ↓We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender